RecruitingNCT06371833

PRIMA EU Retrospective & Prospective

A Multicentric Study Evaluating Clinical and Radiological Outcomes of PRIMA Humeral Stem in Total Shoulder Arthroplasty

Sponsor

Limacorporate S.p.a

Enrollment

60 participants

Start Date

Oct 25, 2024

Study Type

OBSERVATIONAL

Conditions

arthroplasty Shoulder Replacement

Summary

This clinical study aims at evaluating clinical, radiographic and patient-reported outcomes after total anatomic or reverse shoulder replacement using PRIMA humeral stem up to 24 months after surgery, in order to assess the short-term performance of the implant. Furthermore, the objective is also to collect short-term data on the survivorship of the implant and the incidence of complications.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Shoulder Arthroplasy with PRIMA humeral stem for people with replacement, shoulder, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEShoulder Arthroplasy with PRIMA humeral stem

Data collection of population that underwent a total shoulder arthroplasty with PRIMA humeral stem (anatomic configuration or reverse configuration)

Locations(1)

Unit of Shoulder Surgery Romagna/ Cervesi Hospital, Italy

Cattolica, Rimini, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06371833

Related Trials

INHANCE Stemless Reverse Shoulder IDE

NCT0632398019 locations

Postoperative Oral Tranexamic Acid in Patients Undergoing Primary Total Joint Arthroplasty

NCT06832878